Zilovertamab Vedotin (MK‐2140) in Relapsed or Refractory (R/R) Non‐hodgkin Lymphoma (NHL): 14‐month Follow‐up of the Phase 1 Waveline‐001 Study
Hematological Oncology(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological Oncology(2023)